Viewing Study NCT06322095


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2026-02-21 @ 12:13 AM
Study NCT ID: NCT06322095
Status: RECRUITING
Last Update Posted: 2024-10-01
First Post: 2024-03-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors
Sponsor: Suzhou Genhouse Bio Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module